Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg Infect Dis ; 23(10)2017 10.
Article in English | MEDLINE | ID: mdl-28767036

ABSTRACT

Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability and treatment response at 6 months.


Subject(s)
Antitubercular Agents/therapeutic use , Nitroimidazoles/therapeutic use , Oxazoles/therapeutic use , Tuberculosis, Multidrug-Resistant/drug therapy , Adolescent , Female , HIV Infections/complications , Hepatitis C/complications , Humans , Male , Retrospective Studies , Tuberculosis, Multidrug-Resistant/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...